PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F22S9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,000
Award facts
- Contract value 100% obligated
- $11,000.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,000.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 18, 2025, for completion by August 19, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems.
The delivery order falls within AmerisourceBergen's established pharmaceutical supply portfolio under the DLA Troop Support Medical contract, which enables the company to distribute a comprehensive range of medical commodities including brand-name and generic medications, vaccines, specialty pharmaceuticals, medical devices, and related healthcare supplies. As a prime contractor demonstrating consistent capability to meet federal procurement requirements through open competition, AmerisourceBergen supports multiple federal agencies including the Defense Health Agency and U.S. Coast Guard. The contract aligns with DLA's Pharmaceutical Prime Vendor Global Program strategy, which anticipates establishing Generation V contracts with multiple regional awards to ensure comprehensive pharmaceutical support for defense and military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2D825F22S9?
SPE2D825F22S9 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 18, 2025.
How much is contract SPE2D825F22S9 worth?
The government has obligated $11,000 on SPE2D825F22S9.
Is contract SPE2D825F22S9 an order under another contract?
Yes. SPE2D825F22S9 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D825F22S9 competed?
The extent of competition for SPE2D825F22S9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award